BUDGE
发表于 2025-3-25 03:41:01
http://reply.papertrans.cn/43/4279/427834/427834_21.png
毛细血管
发表于 2025-3-25 10:48:44
Cancer Treatment and Researchhttp://image.papertrans.cn/h/image/427834.jpg
别名
发表于 2025-3-25 15:14:30
,Management of Advanced Stage Hodgkin’s Lymphoma,Hodgkin’s lymphoma (HL) is an uncommon malignancy of unknown etiology with an annual incidence in Western populations of 2–3 per 100,000 (.). On average there are 7000 new cases reported in the United States each year, distributed in a bimodal pattern with a first peak in the third decade and a second peak after the age of 50 (., .).
辞职
发表于 2025-3-25 16:53:56
,Pathology of B-Cell Non-Hodgkin’s Lymphomas and Multiple Myeloma,L/SLL), appear to resemble more than one B-cell differentiation stage. Nevertheless, a basic understanding of B-cell differentiation stages and their associated immunophenotypic characteristics facilitates accurate diagnosis and appropriate management of B-NHLs.
Ointment
发表于 2025-3-25 21:11:38
Diffuse Large B-Cell NHL, play a role in the development of new prognostic models that may refine our ability to identify poor-risk patients. With this technology, over the next decade, it is hoped that novel therapeutic targets will be identified, allowing continued improvements in outcome for patients with this disease.
AVERT
发表于 2025-3-26 04:02:00
http://reply.papertrans.cn/43/4279/427834/427834_26.png
Reservation
发表于 2025-3-26 07:16:58
http://reply.papertrans.cn/43/4279/427834/427834_27.png
者变
发表于 2025-3-26 10:22:28
,Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma,of a series of differentiation antigens, termed “cluster of differentiation” (CD) antigens. These characteristics serve as the basis for the World Health Organization (WHO) Classification of Lymphoid Neoplasms [.]. These proteins are also valuable markers for diagnosing and classifying lymphomas, as well as reliable targets for therapy.
asthma
发表于 2025-3-26 15:04:42
,Blood and Bone Marrow Transplantation for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma,) for patients with lymphoma. Initial studies were performed in refractory patients. These studies demonstrated the feasibility of this approach and ushered in more definitive trials in patients with homogenous histologies.
Chromatic
发表于 2025-3-26 20:15:57
http://reply.papertrans.cn/43/4279/427834/427834_30.png